FORMULATION FORUM – Age-Appropriate Pediatric Formulation Development

Jim Huang, PhD, reviews how a pediatric formulation should consider the following factors: difference in physiological and pharmacokinetic of patient populations, dosage form selection, route of administration, dose accuracy, dose flexibility, drug and excipient tolerability (safety and toxicity), patient compliance (palatability/swallowability), stability, and drug accessibility.

EXCLUSIVE ONLINE CONTENT

11/18/2020

XOMA Earns $2-Million Milestone From Takeda

XOMA Corporation recently announced it has earned a $2-million milestone payment from Takeda Pharmaceutical Company Limited as the first patient has been dosed….

11/12/2020

Benefits of Small-Scale Drug Development

Kieran Coffey, Technical Lead at Pfizer CentreOne’s Newbridge facility, discusses the benefits of small-scale processing for process development of tablet products.